mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.04 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.04 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.04 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.04 |